Document Detail

Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease.
MedLine Citation:
PMID:  1519845     Owner:  NLM     Status:  MEDLINE    
The growing number of patients treated with long-term oxygen therapy (LTOT) poses the question which physiologic variables could predict the patients who may benefit the most from this cumbersome and expensive treatment. We wanted to verify if the acute effect of oxygen on pulmonary arterial pressure (PAP) is related to survival on LTOT as was suggested recently in the literature. We studied 46 chronic obstructive pulmonary disease (COPD) patients qualified for LTOT. The acute effects of O2 on pulmonary hemodynamics were assessed by pressure and flow measurements before and after 30 min of O2 breathing via 28% Ventimask. Thirty-nine patients reacted with a fall of the mean PAP of less than 0.7 kPa 5 (mm Hg). These were termed nonresponders (NR). In seven patients, mean PAP fell greater than or equal to 0.7 kPa 5 (mm Hg). They were called responders (R). After the initial investigations, patients were followed up on LTOT for 2 yr or until death. During the first year, four patients died; three from the NR and one from the R group. After 2 yr of LTOT, 15 patients died (12 from NR and 3 from R groups). The 2-yr survival rate was 69% in NR and 57% in R groups, respectively. We conclude that survival on LTOT is not related to the acute effect of oxygen on the PAP in COPD patients investigated in the steady-state period of the disease.
P Sliwiński; I Hawrylkiewicz; D Górecka; J Zieliński
Related Documents :
18488435 - Impairment of small airways in copd patients with frequent exacerbations and effects of...
3552465 - Airway hyperresponsiveness in allergic rhinitis. a risk factor for asthma.
15293615 - Relevance of assessing quadriceps endurance in patients with copd.
19466515 - Effects of chronic obstructive pulmonary disease on coronary atherosclerosis.
22271365 - Henoch-schönlein purpura with hypocomplementemia.
10091165 - Thrombotic risk in thalassemic patients.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The American review of respiratory disease     Volume:  146     ISSN:  0003-0805     ISO Abbreviation:  Am. Rev. Respir. Dis.     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-10-06     Completed Date:  1992-10-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370523     Medline TA:  Am Rev Respir Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  665-9     Citation Subset:  AIM; IM    
Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hemodynamics / drug effects
Lung Diseases, Obstructive / mortality,  physiopathology*,  therapy
Middle Aged
Oxygen / pharmacology*
Oxygen Inhalation Therapy*
Pulmonary Wedge Pressure / drug effects*
Regression Analysis
Survival Analysis
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Corticosteroid administration modifies ozone-induced increases in sheep airway blood flow.
Next Document:  Adenosine is a pulmonary vasodilator in newborn lambs.